Robert Benjamin Stein Insider Trading $AYXC.OB MIMEDX GROUP, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Robert Benjamin Stein.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Robert Benjamin Stein. Robert Benjamin Stein is Director in Protagenic Therapeutics, Inc.\new ($ATRN) and Chief Scientific Officer in AGENUS INC ($AGEN) and President R&D in AGENUS INC ($AGEN) and EVP, Research and Development in MIMEDX GROUP, INC. ($AYXC.OB).

Robert Benjamin Stein in MIMEDX GROUP, INC.

Trading Symbol: AYXC.OB
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Robert Benjamin Stein: EVP, Research and Development
Holdings: 191,068 shares
Latest Transaction: Mar 08 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Robert Benjamin Stein in MIMEDX GROUP, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AGEN, AYXC.OB, PTIX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 08 2021AYXC.OBMIMEDX GROUP, INC.Stein Robert BenjaminEVP, Research and D ...GrantA0.00109,2350191,06881.8 K to 191.1 K (+133.49 %)
Aug 12 2020AYXC.OBMIMEDX GROUP, INC.Stein Robert BenjaminEVP, Research and D ...GrantA6.1181,833500,00081,8330 to 81.8 K

Page:   1